Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding

Psychoneuroendocrinology

Volumn 35, Issue 9, 2010, Pages 1311-1320

  Frokjaer, Vibe G ^a   Erritzoe, David ^a   Juul, Anders ^a   Nielsen, Finn Årup ^a,c   Holst, Klaus ^b   Svarer, Claus ^a   Madsen, Jacob ^a   Paulson, Olaf B ^d   Knudsen, Gitte M ^a  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

5 HT2A; Estrogen; Hormones; PET; Sex; Testosterone

Indexed keywords

ALTANSERIN F 18; ESTRADIOL; RADIOISOTOPE; SEROTONIN 2A RECEPTOR; SEX HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; MALE; NEUROIMAGING; NEUROTRANSMISSION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; SEROTONINERGIC SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; BINDING, COMPETITIVE; CEREBRAL CORTEX; ESTRADIOL; FLUORINE RADIOISOTOPES; HEALTH; HUMANS; KETANSERIN; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RECEPTOR, SEROTONIN, 5-HT2A; YOUNG ADULT;

EID: 77956617751     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.03.002     Document Type: Article

References (51)

1. Adams K.H., Pinborg L.H., Svarer C., Hasselbalch S.G., Holm S., Haugbol S., Madsen K., Frokjaer V., Martiny L., Paulson O.B., Knudsen G.M. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage 2004, 21:1105-1113.
2. Almeida O.P., Yeap B.B., Hankey G.J., Jamrozik K., Flicker L. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch. Gen. Psychiatry 2008, 65:283-289.
3. Bethea C.L., Mirkes S.J., Shively C.A., Adams M.R. Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol. Psychiatry 2000, 47:562-576.
4. Bethea C.L., Lu N.Z., Gundlah C., Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front. Neuroendocrinol. 2002, 23:41-100.
5. Cahill L. Why sex matters for neuroscience. Nat. Rev. Neurosci. 2006, 7:477-484.
6. Cosgrove K.P., Mazure C.M., Staley J.K. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol. Psychiatry 2007, 62(8):847-855.
7. Erritzoe D., Frokjaer V.G., Haugbol S., Marner L., Svarer C., Holst K., Baare W.F., Rasmussen P.M., Madsen J., Paulson O.B., Knudsen G.M. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage 2009, 46:23-30.
8. Fauser B.C., Devroey P., Yen S.S., Gosden R., Crowley W.F., Baird D.T., Bouchard P. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum. Reprod. 1999, 14:2681-2686.
9. Fink G., Sumner B., Rosie R., Wilson H., McQueen J. Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav. Brain Res. 1999, 105:53-68.
10. Freeman E.W., Sammel M.D., Lin H., Nelson D.B. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch. Gen. Psychiatry 2006, 63:375-382.
11. Frokjaer V.G., Erritzoe D., Madsen J., Paulson O.B., Knudsen G.M. Gender and the use of hormonal contraception in women are not associated with cerebral cortical serotonin 2A receptor binding. Neuroscience 2009, 163(2):640-645.
12. Frokjaer V.G., Mortensen E.L., Nielsen F.A., Haugbol S., Pinborg L.H., Adams K.H., Svarer C., Hasselbalch S.G., Holm S., Paulson O.B., Knudsen G.M. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol. Psychiatry 2008, 63:569-576.
13. Gundlah C., Lu N.Z., Bethea C.L. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl) 2002, 160:271-282.
14. Gunther L., Liebscher S., Jahkel M., Oehler J. Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice. Eur. J. Pharmacol. 2008, 593:49-61.
15. Hasselbalch S.G., Madsen K., Svarer C., Pinborg L.H., Holm S., Paulson O.B., Waldemar G., Knudsen G.M. Reduced 5-HT2A receptor binding in patients with mild cognitive impairment. Neurobiol. Aging 2008, 29:1830-1838.
16. Heijnen E.M., Eijkemans M.J., De Klerk C., Polinder S., Beckers N.G., Klinkert E.R., Broekmans F.J., Passchier J., Te Velde E.R., Macklon N.S., Fauser B.C. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet 2007, 369:743-749.
17. Henderson J.A., Bethea C.L. Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques. Endocrine 2008, 33:285-293.
18. Holmes A.P., Blair R.C., Watson J.D., Ford I. Nonparametric analysis of statistic images from functional mapping experiments. J. Cereb. Blood Flow Metab. 1996, 16:7-22.
19. Jovanovic H., Karlsson P., Cerin A., Halldin C., Nordstrom A.L. 5-HT(1A) receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [(11)C] WAY100635 and [(11)C] MADAM PET. Psychiatry Res. 2009, 172:31-37.
20. Kawata M. Roles of steroid hormones and their receptors in structural organization in the nervous system. Neurosci. Res. 1995, 24:1-46.
21. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J. Affect Disord. 1993, 29:85-96.
22. Kugaya A., Epperson C.N., Zoghbi S., van Dyck C.H., Hou Y., Fujita M., Staley J.K., Garg P.K., Seibyl J.P., Innis R.B. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am. J. Psychiatry 2003, 160:1522-1524.
23. Licht C.L., Marcussen A.B., Wegener G., Overstreet D.H., Aznar S., Knudsen G.M. The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J. Neurochem. 2009, 109:1363-1374.
24. Lu N.Z., Bethea C.L. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 2002, 27:12-24.
25. Lu N.Z., Eshleman A.J., Janowsky A., Bethea C.L. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques. Mol. Psychiatry 2003, 8:353-360.
26. McQueen J.K., Wilson H., Sumner B.E., Fink G. Serotonin transporter (SERT) mRNA and binding site densities in male rat brain affected by sex steroids. Brain Res. Mol. Brain Res. 1999, 63:241-247.
27. Meyer J.H., Kapur S., Eisfeld B., Brown G.M., Houle S., DaSilva J., Wilson A.A., Rafi-Tari S., Mayberg H.S., Kennedy S.H. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am. J. Psychiatry 2001, 158:78-85.
28. Moses-Kolko E.L., Berga S.L., Greer P.J., Smith G., Cidis Meltzer C., Drevets W.C. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women. Fertil. Steril. 2003, 80:554-559.
29. Moses E.L., Drevets W.C., Smith G., Mathis C.A., Kalro B.N., Butters M.A., Leondires M.P., Greer P.J., Lopresti B., Loucks T.L., Berga S.L. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol. Psychiatry 2000, 48:854-860.
30. Munk-Olsen T., Laursen T.M., Pedersen C.B., Mors O., Mortensen P.B. New parents and mental disorders: a population-based register study. JAMA 2006, 296:2582-2589.
31. Munk-Olsen T., Laursen T.M., Mendelson T., Pedersen C.B., Mors O., Mortensen P.B. Risks and predictors of readmission for a mental disorder during the postpartum period. Arch. Gen. Psychiatry 2009, 66:189-195.
32. Naughton M., Mulrooney J.B., Leonard B.E. A review of the role of serotonin receptors in psychiatric disorders. Hum. Psychopharmacol. 2000, 15:397-415.
33. O'Connor K.A., Roth B.L. Finding new tricks for old drugs: an efficient route for public-sector drug discovery. Nat. Rev. Drug Discov. 2005, 4:1005-1014.
34. Osterlund M.K., Hurd Y.L. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog. Neurobiol. 2001, 64:251-267.
35. Ostlund H., Keller E., Hurd Y.L. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann. N.Y. Acad. Sci. 2003, 1007:54-63.
36. Pearlstein T., Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J. Psychiatry Neurosci. 2008, 33:291-301.
37. Pearlstein T., Rosen K., Stone A.B. Mood disorders and menopause. Endocrinol. Metab. Clin. North Am. 1997, 26:279-294.
38. Pecins-Thompson M., Brown N.A., Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res. Mol. Brain Res. 1998, 53:120-129.
39. Pigott T.A. Gender differences in the epidemiology and treatment of anxiety disorders. J. Clin. Psychiatry 1999, 60(Suppl. 18):4-15.
40. Pinborg L.H., Adams K.H., Svarer C., Holm S., Hasselbalch S.G., Haugbol S., Madsen J., Knudsen G.M. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach. J. Cereb. Blood Flow Metab. 2003, 23:985-996.
41. Riecher-Rossler A., Hafner H. Schizophrenia and oestrogens-is there an association?. Eur. Arch. Psychiatry Clin. Neurosci. 1993, 242:323-328.
42. Sacher J, Wilson A, Houle S, Rusjan P, Hassan S, Bloomfield P M, Stewart D, Meyer JH. Elevated Brain Monoamine Oxidase A Binding In Early Postpartum. Arch. Gen. Psy. 2010, in press.
43. Simpson E.R. Sources of estrogen and their importance. J. Steroid Biochem. Mol. Biol. 2003, 86:225-230.
44. Skovdahl Hansen H., Lykke Mortensen E. NEO PI-R Manual (Danish version). PsykologiErhverv-et selskab under Dansk psykologisk Forlag 2003.
45. Stockmeier C.A. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J. Psychiatr. Res. 2003, 37:357-373.
46. Su J.Q., Wei L.J. A lack-of-fit test for the mean function in a generalized linear model. J. Amer. Stat. Assoc. 1991, 86:420-426.
47. Sumner B.E., Fink G. Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain. Brain Res. Mol. Brain Res. 1998, 59:205-214.
48. Sumner B.E., Grant K.E., Rosie R., Hegele-Hartung C., Fritzemeier K.H., Fink G. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain. Neurosci. Lett. 2007, 417:95-99.
49. Svarer C., Madsen K., Hasselbalch S.G., Pinborg L.H., Haugbol S., Frokjaer V.G., Holm S., Paulson O.B., Knudsen G.M. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 2005, 24:969-979.
50. Yohai V.J. High breakdown-point and high efficiency robust estimates for regression. Ann. Stat. 1987, 15:642-656.
51. Yonkers K.A., O'Brien P.M., Eriksson E. Premenstrual syndrome. Lancet 2008, 371:1200-1210.